Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARK M AWAD

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1831359355
CMS profile
1127368
Location
NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$47,740.77

49 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $15,534.76 16
E.R. Squibb & Sons, L.L.C. $8,327.96 11
AstraZeneca Pharmaceuticals LP $6,340.53 8
Amgen Inc. $5,841.00 2
Regeneron Pharmaceuticals, Inc. $4,492.62 2
Mirati Therapeutics, Inc. $3,753.70 5
Seagen Inc. $2,500.00 1
Gilead Sciences, Inc. $760.00 1
Abbott Laboratories $140.21 2
AstraZeneca UK Limited $49.99 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

49 matching records · $47,740.77 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 49 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–49 of 49.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $1,770.0011/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016419051 CMS
E.R. Squibb & Sons, L.L.C. $44.4411/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016418953 CMS
E.R. Squibb & Sons, L.L.C. $304.6411/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016418957 CMS
Amgen Inc. $2,596.0011/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020632305 CMS
Merck Sharp & Dohme LLC $150.0011/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048545457 CMS
Merck Sharp & Dohme LLC $6,710.0011/06/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048545459 CMS
Amgen Inc. $3,245.0010/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020632303 CMS
Merck Sharp & Dohme LLC $446.3910/24/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048255683 CMS
Merck Sharp & Dohme LLC $33.6510/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048255685 CMS
Merck Sharp & Dohme LLC $54.4910/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048255687 CMS
Merck Sharp & Dohme LLC $446.3910/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048255681 CMS
E.R. Squibb & Sons, L.L.C. $3,437.2010/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016419211 CMS
E.R. Squibb & Sons, L.L.C. $432.8410/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016419213 CMS
E.R. Squibb & Sons, L.L.C. $14.1610/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016419221 CMS
E.R. Squibb & Sons, L.L.C. $49.5610/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016419225 CMS
Regeneron Pharmaceuticals, Inc. $976.5210/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026999998573 CMS
E.R. Squibb & Sons, L.L.C. $432.8410/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016419207 CMS
E.R. Squibb & Sons, L.L.C. $432.8410/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016419203 CMS
Regeneron Pharmaceuticals, Inc. $3,516.1010/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026999998563 CMS
AstraZeneca Pharmaceuticals LP $1,337.0009/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015875987 CMS
Abbott Laboratories $98.4609/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261019468155 CMS
Gilead Sciences, Inc. $760.0008/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261035501133 CMS
AstraZeneca Pharmaceuticals LP $1,337.0006/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015967197 CMS
Abbott Laboratories $41.7506/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261019219879 CMS
AstraZeneca Pharmaceuticals LP $30.8506/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016175567 CMS
AstraZeneca Pharmaceuticals LP $44.9906/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015979917 CMS
Mirati Therapeutics, Inc. $153.7006/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261057985735 CMS
Mirati Therapeutics, Inc. $1,200.0006/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261057985739 CMS
AstraZeneca UK Limited $49.9906/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017086449 CMS
Mirati Therapeutics, Inc. $1,500.0005/16/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261057985733 CMS
AstraZeneca Pharmaceuticals LP $1,605.0005/15/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016080041 CMS
AstraZeneca Pharmaceuticals LP $1,872.5005/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011662515 CMS
AstraZeneca Pharmaceuticals LP $28.7504/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011873965 CMS
AstraZeneca Pharmaceuticals LP $84.4404/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016100717 CMS
E.R. Squibb & Sons, L.L.C. $257.6204/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016418949 CMS
E.R. Squibb & Sons, L.L.C. $1,151.8204/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016418945 CMS
Merck Sharp & Dohme LLC $150.0003/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048545453 CMS
Merck Sharp & Dohme LLC $6,710.0003/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048545455 CMS
Merck Sharp & Dohme LLC $239.5503/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048255689 CMS
Merck Sharp & Dohme LLC $64.9903/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048705613 CMS
Merck Sharp & Dohme LLC $64.9903/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048705953 CMS
Merck Sharp & Dohme LLC $58.1903/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048705961 CMS
Merck Sharp & Dohme LLC $63.4803/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048705969 CMS
Merck Sharp & Dohme LLC $185.0003/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048705957 CMS
Merck Sharp & Dohme LLC $31.7403/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048705965 CMS
Merck Sharp & Dohme LLC $125.9003/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048705989 CMS
Mirati Therapeutics, Inc. $450.0002/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261057985729 CMS
Seagen Inc. $2,500.0002/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995836363 CMS
Mirati Therapeutics, Inc. $450.0002/02/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261057985727 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $15,343.38 21
PY2020 $16,450.00 8
PY2021 $36,309.50 15
PY2022 $17,862.76 12
PY2023 $47,740.77 49
PY2024 $38,747.64 33
PY2025 $30,704.79 16

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MARK M AWAD, NPI 1831359355. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1831359355.
APA 7
IndustryPayments. (2026). MARK M AWAD, NPI 1831359355 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1831359355
Bluebook
MARK M AWAD, NPI 1831359355, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1831359355.

Source: Centers for Medicare & Medicaid Services, Open Payments.